Ligand Pharmaceuticals Incorporated (LGND) Return on Equity (ROE) and Return on Assets (ROA)
Ligand Pharmaceuticals Incorporated (LGND) return on equity (ROE) and return on assets (ROA) history. Calculate ROE/ROA in Excel with MarketXLS.
ROE & ROA Data
| Period | ROE | ROA |
|---|---|---|
| 2016-12-31 | -0.88% | -0.54% |
| 2017-12-31 | 3.00% | 1.87% |
| 2018-12-31 | 25.55% | 11.37% |
| 2019-12-31 | 82.02% | 42.10% |
| 2020-12-31 | -0.42% | -0.22% |
| 2021-12-31 | 6.96% | 4.40% |
| 2022-12-31 | -5.58% | -4.37% |
| 2023-12-31 | 7.44% | 6.63% |
| 2024-12-31 | -0.49% | -0.43% |
| 2025-12-31 | 12.23% | 7.97% |
Return on equity divides net income by total shareholder equity at the period end. Return on assets divides the same net income by total assets at the period end. A figure reads N/A when the divisor is missing or not positive, because the ratio is not meaningful then.
Get Ligand Pharmaceuticals Incorporated Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Return_on_Average_Equity("LGND", 2025, "")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | LGND | $311.13 | +3.09% | 0.17M |
| 3 | ||||
| 4 | ||||
| 5 |